Global Small Interfering RNA (siRNA) Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Delivery (Lipid Nanoparticles (LNPs), Conjugates), By Indication (Hereditary Transthyretin-mediated Amyloidosis, Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1, Primary Hypercholesterolemia, Others), By RoA (Intravenous (IV), Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
$5550
Total
$5550
Need assistance?
Call us or write to us:
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies